Vaccine maker Catalent eligible for $2M from state as part of $230M expansion By: Baltimore Business Journal via Business Journals October 29, 2021 at 13:45 PM EDT This is the latest expansion in Maryland for the New Jersey-based vaccine maker which acquired Paragon Gene Therapy in 2019. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
